Nature Biotechnology
From Wikipedia, the free encyclopedia
Nature Biotechnology | |
---|---|
Discipline | Biotechnology |
Language | English |
Abbreviated title | Nat Biotechnol |
Publisher (country) | Nature Publishing Group (UK) |
Publication history | 1996 to present |
Website | http://www.nature.com/nbt/index.html |
ISSN | 1087-0156 |
Nature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.
Nature Biotechnology is a continuation of Bio/technology (Biotechnology (N Y); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process.
Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.
The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/technology was Harvey Bialy, who held the post until 1996.